Decreased plasma adiponectin concentrations are closely related to steatosis in hepatitis C virus-infected patients

被引:92
作者
Petit, JM [1 ]
Minello, A
Jooste, V
Bour, JB
Galland, F
Duvillard, L
Verges, B
Olsson, NO
Gambert, P
Hillon, P
机构
[1] Ctr Hosp Univ Bocage, Serv Diabetol & Endocrinol, Boite Postale 77908, F-21079 Dijon, France
[2] Ctr Hosp Univ Bocage, Serv Hepatogastroenterol, F-21079 Dijon, France
[3] Ctr Hosp Univ Bocage, Virol Lab, F-21079 Dijon, France
[4] Ctr Hosp Univ Bocage, Lab Inst Natl Sante, F-21079 Dijon, France
[5] Ctr Hosp Univ Bocage, Rech Med Unite 498, F-21079 Dijon, France
[6] Ctr Hosp Univ Bocage, Immunol Lab, F-21079 Dijon, France
关键词
D O I
10.1210/jc.2004-1266
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The mechanisms underlying steatosis during hepatitis C virus (HCV) infection are complex and multifactorial. Obesity is a well-recognized risk factor for the development of steatosis in chronic hepatitis C infection. The aim of our study was to investigate the role of adipocytokines in HCV-related steatosis. Therefore, we hypothesized that the endocrine function of adipose tissue could be, in part, responsible for HCV-related steatosis. Seventy-one consecutive untreated chronic hepatitis C patients were studied to assess the effects of adipocytokines, body mass index (BMI), age, and HCV genotype on steatosis. We used ELISA to determine serum adiponectin, leptin, and soluble TNF receptors I and II concentrations. Results: Steatosis was observed in 42 (59.1%) patients. BMI was significantly associated with leptin (r = 0.64; P = 0.0001) and was border significantly associated with adiponectin concentrations (r = -0.22; P = 0.06). In univariate analyses, age, HCV genotype 3, BMI, increased leptin level, increased insulin level, and decreased adiponectin concentration were associated with steatosis. In multivariate analysis, steatosis was significantly associated with low adiponectin concentration, age, HCV genotype 3, and aspartate aminotransferase (ASAT) level, whereas steatosis was not associated with leptin, insulin, and BMI. Conclusion: In chronic HCV patients, hypoadiponectinemia is significantly associated with the development of liver steatosis. The fact that the plasma levels of adiponectin inversely correlate with steatosis in HCV-infected subjects suggests that hypoadiponectinemia may contribute to hepatic steatosis progression and liver injury in this population. One practical implication is that therapy to increase circulating adiponectin concentration, such as overweight reduction or thiazolidinediones, provides the potential to improve steatosis in chronic hepatitis C infection.
引用
收藏
页码:2240 / 2243
页数:4
相关论文
共 20 条
  • [1] Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity
    Adinolfi, LE
    Gambardella, M
    Andreana, A
    Tripodi, MF
    Utili, R
    Ruggiero, G
    [J]. HEPATOLOGY, 2001, 33 (06) : 1358 - 1364
  • [2] Adipose tissue as an endocrine organ
    Ahima, RS
    Flier, JS
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2000, 11 (08) : 327 - 332
  • [3] Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients
    Bajaj, M
    Suraamornkul, S
    Piper, P
    Hardies, LJ
    Glass, L
    Cersosimo, E
    Pratipanawatr, T
    Miyazaki, Y
    Defronzo, RA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) : 200 - 206
  • [4] Giannini E, 2000, AM J GASTROENTEROL, V95, P3211, DOI 10.1111/j.1572-0241.2000.03294.x
  • [5] Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis
    Hourigan, LF
    Macdonald, GA
    Purdie, D
    Whitehall, VLJ
    Shorthouse, C
    Clouston, A
    Powell, EE
    [J]. HEPATOLOGY, 1999, 29 (04) : 1215 - 1219
  • [6] Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin
    Kamada, Y
    Tamura, S
    Kiso, S
    Matsumoto, H
    Saji, Y
    Yoshida, Y
    Fukui, K
    Maeda, N
    Nishizawa, H
    Nagaretani, H
    Okamoto, Y
    Kihara, S
    Miyagawa, J
    Shinomura, Y
    Funahashi, T
    Matsuzawa, Y
    [J]. GASTROENTEROLOGY, 2003, 125 (06) : 1796 - 1807
  • [7] Adipose tissue as an endocrine organ
    Kershaw, EE
    Flier, JS
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) : 2548 - 2556
  • [8] Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease
    Lonardo, A
    Adinolfi, LE
    Loria, P
    Carulli, N
    Ruggiero, G
    Day, CP
    [J]. GASTROENTEROLOGY, 2004, 126 (02) : 586 - 597
  • [9] Adiponectin, hepatocellular dysfunction and insulin sensitivity
    López-Bermejo, A
    Botas, P
    Funahashi, T
    Delgado, E
    Kihara, S
    Ricart, W
    Fernández-Real, JM
    [J]. CLINICAL ENDOCRINOLOGY, 2004, 60 (02) : 256 - 263
  • [10] Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcohol
    Monto, A
    Alonzo, J
    Watson, JJ
    Grunfeld, C
    Wright, TL
    [J]. HEPATOLOGY, 2002, 36 (03) : 729 - 736